Erratum to “Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma”

BioMed Research International - United States
doi 10.1155/2019/5256364
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Expression of MAGE-A12 in Oral Squamous Cell Carcinoma

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2008English

CRMAGE: CRISPR Optimized MAGE Recombineering

Scientific Reports
Multidisciplinary
2016English

Evaluation of MAGE-1 and MAGE-3 as Tumour-Specific Markers to Detect Blood Dissemination of Hepatocellular Carcinoma Cells

British Journal of Cancer
Cancer ResearchOncology
2002English

MAGE: A Distributed Programming Model

English

A Clinical Study of a Cell-Based MAGE-A3 Active Immunotherapy in Advanced Melanoma Patients

Journal of Cancer
Oncology
2011English

MAGE-D1 Regulates Expression of Depression-Like Behavior Through Serotonin Transporter Ubiquitylation

Journal of Neuroscience
Neuroscience
2012English

Quantitative Expression and Immunogenicity of MAGE-3 and -6 in Upper Aerodigestive Tract Cancer

International Journal of Cancer
Cancer ResearchOncology
2009English

Correlation Between Tumor Regression and T Cell Responses in Melanoma Patients Vaccinated With a MAGE Antigen

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2004English

The Anti-Tumor Immune Response Induced by a Combination of MAGE-3/MAGE-n-derived Peptides

Oncology Reports
MedicineCancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy